Laboratory Average Receivables from 2010 to 2024

LH Stock  USD 241.16  0.99  0.41%   
Laboratory's Average Receivables is decreasing with slightly volatile movements from year to year. Average Receivables is predicted to flatten to about 1.6 B. For the period between 2010 and 2024, Laboratory, Average Receivables quarterly trend regression had mean deviation of  70,997,333 and range of 409.6 M. View All Fundamentals
 
Average Receivables  
First Reported
2010-12-31
Previous Quarter
1.8 B
Current Value
1.6 B
Quarterly Volatility
114.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Laboratory financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Laboratory's main balance sheet or income statement drivers, such as Interest Expense of 209.6 M, Total Revenue of 12.8 B or Gross Profit of 2 B, as well as many indicators such as Price To Sales Ratio of 1.57, Dividend Yield of 0.0122 or PTB Ratio of 3.28. Laboratory financial statements analysis is a perfect complement when working with Laboratory Valuation or Volatility modules.
  
Check out the analysis of Laboratory Correlation against competitors.

Currently Active Assets on Macroaxis

Check out the analysis of Laboratory Correlation against competitors.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.05)
Dividend Share
2.88
Earnings Share
5.28
Revenue Per Share
151.028
Quarterly Revenue Growth
0.074
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.